PHEN: Session I: September 8th Register Now!

The Impact of COVID-19 On The Prostate Cancer Racial Disparity

COVID-19 delayed prostate cancer early detection screening and treatments. It also ushered in an increased use of telemedicine for prostate cancer care which is anticipated to expand and become more of a standard of care. This session will assess the impact of the pandemic, with a focus on how the increased use of telemedicine will impact the prostate cancer racial disparity based on the experiences and perspectives of doctors and patients.


All Sessions 1:00 PM to 3:30 PM ET

Welcome and Opening RemarksMr. Thomas Farrington, President and Founder, PHEN

RemarksCongressman Gregory W. Meeks (D5-NY)

ModeratorEdith Mitchell, MD, MACP, FCPP, FRCP, Clinical Professor of Medicine and Medical Oncology; Department of Medical Oncology, Director, Center to Eliminate Cancer Disparities, Associate Director, Diversity Affairs, Sidney Kimmel Cancer Center at Jefferson

The COVID-19 Pandemic and Increased Telemedicine Use for Prostate Cancer: Daniela Wittman, PhD, MSW, Clinical Professor of Medicine, University of Michigan

Questions and Answers

PHEN Survey Results of Black Patients’ experiences and perspectives on Telemedicine: Keith Crawford, MD, PhD, Director of Clinical Trials and Patient Education, PHEN

Panelist Discussion: How Will Increased Telemedicine Impact the Prostate Cancer Racial Disparity?

Closing Remarks


Be the first to comment

Leave a Reply

Your email address will not be published.


* Copy This Password *

* Type Or Paste Password Here *